NeoGenomics, Inc.

NEO ·Healthcare, Diagnostics & Research, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2022

Total Assets: $1.74B

Liabilities Breakdown FY2022

Total Liabilities: $742.0M